AB Science announced that it has received new authorizations to resume patient enrollment in its Phase 3 studies of masitinib

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing